Skip to main content
SpringerLink
Log in
Book cover

Pigmented Ethnic Skin and Imported Dermatoses pp 399–413Cite as

Tumors in Pigmented Skin

  • Chapter
  • First Online:

Abstract

Skin cancer is worldwide the most common malignancy; non-melanoma skin cancer and malignant melanoma together represent 40% of all neoplasms in white Caucasians [1]. The worldwide incidence for basal cell carcinoma varies widely with highest rates in Australia >1000/100,000/person-year and lowest in parts of Africa <1/100,000/person-year. In the UK the average incidence rates were 76/100,000/person-year and 22/100,000 person-year for basal cell and squamous cell carcinoma, respectively [2]. In individuals with pigmented ethnic skin, the incidence of skin cancer is clearly lower as compared with white-skinned individuals, possibly as a result of the photoprotective effects of melanin [3], but skin cancer is often associated with greater mortality and morbidity in pigmented skin. This may be associated either with late diagnosis of the neoplasms in an advanced stage or with different tumor characteristics in populations with pigmented ethnic skin. It is important to further assess any differences of skin cancer between Caucasian and non-Caucasian populations and evaluate the etiology and risk factors in skin of color for developing cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ridky TW. Nonmelanoma skin cancer. J Am Acad Dermatol. 2007;57:484–501.

    Article  PubMed  Google Scholar 

  2. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of non melanoma skin cancer. Br J Dermatol. 2012;166:1069–80.

    Article  CAS  PubMed  Google Scholar 

  3. Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008;84:539–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Rubin A, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353:2262–9.

    Article  CAS  PubMed  Google Scholar 

  5. Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55:741–60.

    Article  PubMed  Google Scholar 

  6. Byrd-Miles K, Toombs EL, Peck GL. Skin cancer in individuals of African, Asian, Latin American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians. J Drugs Dermatol. 2007;6:10–6.

    PubMed  Google Scholar 

  7. Rogers HW, Weinstok MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151:1081–6.

    Article  PubMed  Google Scholar 

  8. Asgari MM, Moffet HH, Ray GT, et al. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998-2012. JAMA Dermatol. 2015;151:976–81.

    Article  PubMed  Google Scholar 

  9. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of non melanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol. 1995;131:157–63.

    Article  CAS  PubMed  Google Scholar 

  10. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63:8–18.

    Article  CAS  PubMed  Google Scholar 

  11. Lear JT, Tan BB, Smith AG, et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med. 1997;90:371–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Agbai ON, Buster K, Sanchez M, et al. Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public. J Am Acad Dermatol. 2014;70:748–62.

    Article  PubMed  Google Scholar 

  13. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer. 1995;75(suppl):667–73.

    Article  CAS  PubMed  Google Scholar 

  14. Kundu RV, Patterson S. Dermatologic conditions in skin of color: part I. Special considerations for common skin disorders. Am Fam Physician. 2013;87:850–6.

    PubMed  Google Scholar 

  15. Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997;69:299–308.

    Article  CAS  PubMed  Google Scholar 

  16. Kulkarni P, Brashear R, Chuang TY. Nevoid basal cell carcinoma syndrome in a person with dark skin. J Am Acad Dermatol. 2003;49:332–5.

    Article  PubMed  Google Scholar 

  17. Halpern AC, Kopp LP. Awareness, knowledge and attitudes to non-melanoma skin cancer and actinic keratosis among the general public. Int J Dermatol. 2005;44:107–11.

    Article  PubMed  Google Scholar 

  18. Montague M, Borland MR, Sinclair C. Slip! Slop! Slap! And SunSmart, 1980-2000: skin cancer control and 20 years of population-based campaigning. Health Educ Behav. 2001;28:290–305.

    Article  CAS  PubMed  Google Scholar 

  19. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27:3–9.

    Article  PubMed  Google Scholar 

  20. SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Beta Version. Surveillance Research Program, National Cancer Institute. Available from http://seer.cancer.gov/explorer/.

  21. Hu S, Parmet Y, Allen G, et al. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol. 2009;145:1369–74.

    PubMed  Google Scholar 

  22. Rouhani P, Hu S, Kirsner RS. Melanoma in Hispanic and black Americans. Cancer Control. 2008;15:248–53.

    Article  PubMed  Google Scholar 

  23. Clairwood M, Ricketts J, Grant-Kels J, et al. Melanoma in skin of color in Connecticut: an analysis of melanoma incidence and stage at diagnosis in non-Hispanic blacks, non-Hispanic whites, and Hispanics. Int J Dermatol. 2014;53:425–33.

    Article  PubMed  Google Scholar 

  24. Watson M, Johnson CJ, Chen VW, et al. Melanoma surveillance in the United States: overview of methods. J Am Acad Dermatol. 2011;65(suppl 1):S6–16.

    PubMed  Google Scholar 

  25. Cartee TV, Kini SP, .Chen SC: Melanoma reporting to central cancer registries by US dermatologists: an analysis of the persistent knowledge and practice gap. J Am Acad Dermatol, 2011; 65(suppl 1): S124–S325.

    PubMed  Google Scholar 

  26. Hu S, Soza-Vento RM, Parker DF, et al. Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County. Florida Arch Dermatol. 2006;142:704–8.

    PubMed  Google Scholar 

  27. Cockburn MG, Zadnick J, Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer. 2006;106:1162–8.

    Article  PubMed  Google Scholar 

  28. Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene. 2003;22:3042–52.

    Article  CAS  PubMed  Google Scholar 

  29. Park SL, Le Marchand L, Wilkens LR, et al. Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort. Cancer Prev Res (Phila). 2012;5:423–34.

    Article  Google Scholar 

  30. Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations-US surveillance, epidemiology, and end results (SEER) program, 1992 to 2001. Arch Dermatol. 2005;141:477–81.

    Article  PubMed  Google Scholar 

  31. Hu S, Ma F, Collado-Mesa F, et al. UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol. 2004;140:819–24.

    Article  PubMed  Google Scholar 

  32. Tadokoro T, Kobayashi N, Zmudzka BZ, et al. UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin. FASEB J. 2003;17:1177–8.

    Article  CAS  PubMed  Google Scholar 

  33. Akslen LA, Puntervoll H, Bachmann IM, et al. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. Melanoma Res. 2008;18:29–35.

    Article  CAS  PubMed  Google Scholar 

  34. Saldanha G, Potter L, Daforno P, et al. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies. Clin Cancer Res. 2006;12:4499–505.

    Article  CAS  PubMed  Google Scholar 

  35. Ibrahim ZA, Narihan MZ, Ojep DN, et al. Cyclin D1 expression in acral melanoma: a case control study in Sarawak. Malays J Pathol. 2012;34:89–95.

    PubMed  Google Scholar 

  36. Pasquali E, García-Borrón JC, Fargnoli MC, et al. MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer. 2015;136:618–31.

    PubMed  CAS  Google Scholar 

  37. Lu J, Dai B, Kong Y, et al. Acral melanoma in Chinese: a clinicopathological and prognostic study of 142 cases. Sci Rep. 2016;6(31432)

    Google Scholar 

  38. Bradford PT, Goldstein MA, Master ML, et al. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145:427–34.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Soon SL, Solomon AR Jr, Papadopoulos D, et al. Acral lentiginous melanoma mimicking benign disease: the Emory experience. J Am Acad Dermatol. 2003;48:183–8.

    Article  PubMed  Google Scholar 

  40. Lino-Silva LS, Domínguez-Rodríguez JA, Aguilar-Romero JM, et al. Melanoma in Mexico: clinicopathologic features in a population with predominance of acral lentiginous subtype. Ann Surg Oncol. 2016;23:4189–94.

    Article  PubMed  Google Scholar 

  41. Seleye-Fubara D, Etebu EN. Histological review of melanocarcinoma in Port Harcourt. Niger J Clin Pract. 2005;8:110–3.

    PubMed  CAS  Google Scholar 

  42. Lodder JV, Simson W, Becker PJ. Malignant melanoma of the skin in black south Africans: a 15-year experience. S Afr J Surg. 2010;3:76–9.

    Google Scholar 

  43. Phan A, Touzet S, Dalle S, et al. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol. 2006;155:561–9.

    Article  CAS  PubMed  Google Scholar 

  44. Zebary A, Omholt K, Vassilaki I, et al. KIT, NRAS, BRAF and PTEN mutations in a Swedish sample with acral lentiginous melanoma. J Dermatol Sci. 2013;72:284–9.

    Article  CAS  PubMed  Google Scholar 

  45. Namiki T, Coelho SG, Hearing VJ. NUAK2: an emerging acral melanoma oncogene. Oncotarget. 2011;2:695–704.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Haigh P, DiFronzo L, McCready D. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg. 2003;46:419–26.

    PubMed  PubMed Central  Google Scholar 

  47. Agarwala SS. Current systemic therapy for metastatic melanoma. Expert Rev Anticancer Ther. 2009;9:587–95.

    Article  CAS  PubMed  Google Scholar 

  48. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–85.

    Article  CAS  PubMed  Google Scholar 

  49. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States 1973-2002. Arch Dermatol. 2007;143:854–9.

    Article  PubMed  Google Scholar 

  50. Weinstock MA, Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health. 1999;89:1240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Weinstock MA, Reynes JF. The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States. Cancer. 1999;85:208–12.

    Article  CAS  PubMed  Google Scholar 

  52. Kim EJ, Hess S, Richardson SK, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest. 2005;115:798–812.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Litvinov IV, Shtreis A, Kobayashi K, et al. Investigating potential exogenous tumor initiating and promoting factors for cutaneous T-cell lymphomas (CTCL), a rare skin malignancy. Oncoimmunology. 2016;5:e1175799.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Hwang ST, Janik JE, Jaffe ES, et al. Mycosis fungoides and Sézary syndrome. Lancet. 2008(9616); 371:945–57.

    Google Scholar 

  55. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002;46:95–106.

    Article  PubMed  Google Scholar 

  56. Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 6.5-year follow-up of 9 patients. J Am Acad Dermatol. 2000;42:33–9.

    Article  CAS  PubMed  Google Scholar 

  57. Möbs M, Knott M, Fritzen B, et al. Diagnostic tools in Sezary syndrome. G Ital Dermatol Venereol. 2010;145:385–91.

    PubMed  Google Scholar 

  58. Macaulay WL. Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign - histologically malignant. Arch Dermatol. 1968;97:23–30.

    Article  CAS  PubMed  Google Scholar 

  59. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch cutaneous lymphoma group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95:3653–61.

    PubMed  CAS  Google Scholar 

  60. Wilcox RA. Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91:1052–5.

    Article  PubMed  Google Scholar 

  61. Assaf C, Hummel M, Steinhoff M, et al. Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications. Blood. 2005;105:503–10.

    Article  CAS  PubMed  Google Scholar 

  62. Möbs M, Cerroni L, Flaig MJ, et al. Molecular diagnostics in cutaneous lymphomas. J Dtsch Dermatol Ges. 2013;11(suppl 4):25–35.

    Article  PubMed  Google Scholar 

  63. Trautinger F, Eder J, Assaf C, et al. European organisation for research and treatment of Cancer Consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - update 2017. Eur J Cancer. 2017;77:57–74.

    Article  PubMed  Google Scholar 

  64. Newman PL, Fletcher CD. Smooth muscle tumours of the external genitalia: clinicopathological analysis of a series. Histopathology. 1991;18:523–9.

    Article  CAS  PubMed  Google Scholar 

  65. Smit DL, Mensenkamp AR, Badeloe S. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet. 2011;79:49–59.

    Article  CAS  PubMed  Google Scholar 

  66. Badeloe S, van Geel M, van Steensel MA, et al. From gene to disease; cutaneous leiomyomatosis. Ned Tijdschr Geneeskd. 2007;151:300–4.

    PubMed  CAS  Google Scholar 

  67. Fletcher CDM. Soft tissue tumors. In: Fletcher CDM, editor. Diagnostic histopathology of tumors. 3rd ed. Philadelphia: Churchill Livingstone; 2007. p. 1527–93.

    Google Scholar 

  68. Badeloe S, Frank J. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis. Eur J Dermatol. 2009;19:545–51.

    PubMed  CAS  Google Scholar 

  69. Raj S, Calonje E, Kraus M, et al. Cutaneous pilar leiomyoma: clinicopathologic analysis of 53 lesions in 45 patients. Am J Dermatopathol. 1997;19:2–9.

    Article  CAS  PubMed  Google Scholar 

  70. Malhotra P, Walia H, Singh A, et al. Leiomyoma cutis: a clinopathological series of 37 cases. Indian J Dermatol. 2010;55:337–41.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Rongioletti F, Fausti V, Ferrando B, et al. A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed’s syndrome). Dermatology. 2010;221:378–80.

    Article  CAS  PubMed  Google Scholar 

  72. Thompson JA Jr. Therapy for painful cutaneous leiomyomas. J Am Acad Dermatol. 1985;13:865–7.

    Article  PubMed  Google Scholar 

  73. Christenson LJ, Smith K, Arpey CJ. Treatment of multiple cutaneous leiomyomas with CO2 laser ablation. Dermatol Surg. 2000;26:319–22.

    Article  CAS  PubMed  Google Scholar 

  74. Kim G. Multiple cutaneous and uterine leiomyomatosis (Reed's syndrome). Dermatol Online J. 2005;11:21.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Venerology, HELIOS Klinikum Krefeld, Krefeld, Germany

    Chalid Assaf

  2. Service de Dermatologie, Centre Hospitalier Universitaire, Kigali, Rwanda

    Alice U. Amani

  3. Department of Dermatology, University of California, Davis School of Medicine, Sacramento, CA, USA

    Egemen Yildiz

  4. Faculty of Medicine, Hacettepe University, Ankara, Turkey

    Egemen Yildiz

  5. Department of Dermatology, University of California, Davis School of Medicine, Sacramento, CA, USA

    Sam T. Hwang M.D., Ph.D.

Authors
  1. Chalid Assaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alice U. Amani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Egemen Yildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sam T. Hwang M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chalid Assaf .

Editor information

Editors and Affiliations

  1. The Free University of Berlin, Medical School Charité, Berlin, Germany

    Constantin E. Orfanos

  2. Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Saxony-Anhalt, Germany

    Christos C. Zouboulis

  3. Department of Dermatology and Venereology, HELIOS Klinikum Krefeld, Krefeld, Nordrhein-Westfalen, Germany

    Chalid Assaf

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Assaf, C., Amani, A.U., Yildiz, E., Hwang, S.T. (2018). Tumors in Pigmented Skin. In: Orfanos, C., Zouboulis, C., Assaf, C. (eds) Pigmented Ethnic Skin and Imported Dermatoses. Springer, Cham. https://doi.org/10.1007/978-3-319-69422-1_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-69422-1_36

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-69421-4

  • Online ISBN: 978-3-319-69422-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation